| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/03/2011 | CN101253180B 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands |
| 08/03/2011 | CN101184756B Isoflavonoid dimers |
| 08/03/2011 | CN101119973B 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors |
| 08/02/2011 | US7989661 Human ADAM-10 inhibitors |
| 08/02/2011 | US7989602 Synthetic molecules having immune activity |
| 08/02/2011 | US7989490 Injectable formulations of taxanes for cad treatment |
| 08/02/2011 | US7989182 Nucleic acid encoding SCN1A variant |
| 08/02/2011 | US7988956 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 08/02/2011 | US7988952 Condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns |
| 08/02/2011 | CA2503196C Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| 08/02/2011 | CA2496538C Boronic ester and acid compounds, synthesis and uses |
| 08/02/2011 | CA2489209C New derivatives of arylsulfonamides and use thereof in therapy |
| 08/02/2011 | CA2488242C Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 08/02/2011 | CA2475780C 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, their use to prepare drugs for treatment of immunological diseases |
| 08/02/2011 | CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor |
| 08/02/2011 | CA2447010C Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2011 | CA2442682C Monocyte-specific particulate delivery vehicle |
| 08/02/2011 | CA2441690C Method for the identification of antigenic peptides |
| 08/02/2011 | CA2419285C New uses for amino acid anticonvulsants |
| 08/02/2011 | CA2395593C Azaindoles |
| 08/02/2011 | CA2364451C Agent for treatment of arthritic disease |
| 08/02/2011 | CA2323207C Food products having enhanced cocoa polyphenol content and processes for producing same |
| 07/28/2011 | WO2011090062A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | WO2011089550A1 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application |
| 07/28/2011 | WO2011089529A1 Salicylate fatty acid derivatives |
| 07/28/2011 | WO2011089168A2 Special composition for the use thereof as a drug |
| 07/28/2011 | WO2011088688A1 Polymer micelle medicine carrier comprising amino acid as stabilizer |
| 07/28/2011 | WO2011034962A3 Compounds that modulate intracellular calcium |
| 07/28/2011 | US20110184220 Methods for the treatment of radiation or chemotherapy-induced tissue damage |
| 07/28/2011 | US20110184066 Ketoprofen Lysine Salt-Containing Aqueous Patch |
| 07/28/2011 | US20110184061 Thiocolchicine and colchicine analogs, methods of making and methods of use thereof |
| 07/28/2011 | US20110184046 Compositions And Methods For Inhibiting Expression Of GSK-3 Genes |
| 07/28/2011 | US20110184035 Methods of treating degenerative diseases/injuries |
| 07/28/2011 | US20110184034 Severe sepsis preventive therapeutic agent |
| 07/28/2011 | US20110184032 Novel Phenylamino Isonicotinamide Compounds |
| 07/28/2011 | US20110184026 C4-substituted alpha-keto oxazoles |
| 07/28/2011 | US20110184022 Organic Compounds |
| 07/28/2011 | US20110184020 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof For Treating Pain and Other Conditions |
| 07/28/2011 | US20110183997 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/28/2011 | US20110183994 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 07/28/2011 | US20110183986 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/28/2011 | US20110183985 Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors |
| 07/28/2011 | US20110183981 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/28/2011 | US20110183977 Benzene, pyridine, and pyridazine derivatives |
| 07/28/2011 | US20110183973 Novel Compounds |
| 07/28/2011 | US20110183966 Aminopyridine kinase inhibitors |
| 07/28/2011 | US20110183960 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 07/28/2011 | US20110183947 Alpha-keto heterocycles as faah inhibitors |
| 07/28/2011 | US20110183924 Methods and systems for annotating biomolecular sequences |
| 07/28/2011 | US20110183908 Yopm as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions |
| 07/28/2011 | US20110183895 Polyheterocyclic compounds highly potent as hcv inhibitors |
| 07/28/2011 | US20110183890 Methods for modulating angiogenesis via dystrophin dp71 |
| 07/28/2011 | US20110183889 Salicylanilide modified peptides for use as oral therapeutics |
| 07/28/2011 | US20110183886 Melanocortin receptor ligands |
| 07/28/2011 | US20110183885 Neo-tryptophan |
| 07/28/2011 | US20110183011 Composition and method for topical treatment of skin lesions |
| 07/28/2011 | US20110183006 Compositions and methods for treating osteoarthritis |
| 07/28/2011 | US20110183000 Artificial bone material having controlled calcium ion elution |
| 07/28/2011 | US20110182995 Medical and dental biomaterial and method of use for the same |
| 07/28/2011 | US20110182986 Controlled release composition |
| 07/28/2011 | US20110182984 High Content Sodium Ibuprofen Granules, Their Preparation And Their Use In Preparing Non-Effervescent Solid Dosage Forms |
| 07/28/2011 | US20110182980 Composition for suppressing expression of target gene |
| 07/28/2011 | US20110182947 Hydrogel-driven drug dosage form |
| 07/28/2011 | US20110182946 Formation of Nanostructured Particles of Poorly Water Soluble Drugs and Recovery by Mechanical Techniques |
| 07/28/2011 | US20110182934 Immune system stimulating nutrition |
| 07/28/2011 | US20110182922 Peptides of il1 beta and tnf alpha and method of treatment using same |
| 07/28/2011 | US20110182920 Identification of a novel cysteine-rich cell penetrating peptide |
| 07/28/2011 | US20110182914 Methods and compositions |
| 07/28/2011 | US20110182895 Antibody variants |
| 07/28/2011 | US20110182894 Methods of treating diabetes using IL-1beta antibodies |
| 07/28/2011 | US20110182893 Prevention and treatment of amyloidogenic diseases |
| 07/28/2011 | US20110182891 Pharmaceutical dosage form comprising polymeric carrier composition |
| 07/28/2011 | US20110182889 Compositions and methods for the treatment of natural killer cell related diseases |
| 07/28/2011 | US20110182849 Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents |
| 07/28/2011 | US20110182828 C20-c21 substituted glucocorticoid receptor agonists |
| 07/28/2011 | US20110182822 Biomarkers for Painful Intervertebral Discs and Methods of Use Thereof |
| 07/28/2011 | CA2792993A1 Special composition for the use thereof as a drug |
| 07/28/2011 | CA2787476A1 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application |
| 07/28/2011 | CA2787248A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | CA2786776A1 Drug-eluting insertable medical device for treating acute myocardial infarction, thrombus containing lesions and saphenous-vein graft lesions |
| 07/27/2011 | EP2348048A1 Antagonistic Anti-HTNFSF13B Human Antibodies |
| 07/27/2011 | EP2348032A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 07/27/2011 | EP2347771A1 Peptide-based compounds for targeted imaging |
| 07/27/2011 | EP2347768A1 Novel use application of sugar chain-recognizing receptor |
| 07/27/2011 | EP2347766A1 Use of TNFalpha antibodies and another drug |
| 07/27/2011 | EP2346878A1 Fused pyridine derivatives as kinase inhibitors |
| 07/27/2011 | EP2346868A1 Azaindazole compounds as ccr1 receptor antagonists |
| 07/27/2011 | EP2346866A1 Beta-carboline sulphonylurea derivatives as ep4 receptor antagonists |
| 07/27/2011 | EP2346843A2 Substituted benzamides as cannabinoid receptor ligands |
| 07/27/2011 | EP2346841A2 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them |
| 07/27/2011 | EP2346820A1 Oxycarbamoyl compounds and the use thereof |
| 07/27/2011 | EP2346512A1 Composition for prevention and treatment of allergic and/or inflammatory diseases |
| 07/27/2011 | EP2346510A1 Use of triterpenic and anthraquinone glycosides as substances exerting hydragogue activity on mucosa of the upper respiratory tract, for the treatment of upper respiratory tract diseases |
| 07/27/2011 | EP2346504A1 Combinations comprising bicyclic s1p lyase inhibitors |
| 07/27/2011 | EP1945626B1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists |
| 07/27/2011 | EP1709046B1 P38 kinase inhibitors |
| 07/27/2011 | EP1682135B1 salt of a tetrahydropyranyl cyclopentyl tetrahydropyridopyridine derivative as CCR2-antagonist |
| 07/27/2011 | EP1641764B1 5-membered heterocycle-based p38 kinase inhibitors |
| 07/27/2011 | EP1638964B1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/27/2011 | EP1490355B1 Indolylmaleimide derivatives |